COMMENTARY: Review: Anticonvulsants are better than placebo for reducing the frequency of migraine attacks

Chessman, Alexander W.
January 2005
ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p21
Academic Journal
The article reports that anticonvulsants are better than placebo for reducing the frequency of migraine attacks. Many patients in studies come from such specialized trial settings as headache or neurology clinics. Patients presenting to these centers might have headaches that are more difficult to treat. Antiepileptic medications have shown similar results to other classes of drugs commonly used for prophylaxis in reducing the frequency and intensity of migraines by about 40 percent.


Related Articles

  • Epilepsy.  // Current Medical Literature: Neurology;2008, Vol. 24 Issue 3, p81 

    This article discusses several studies on epilepsy. The first study suggests an increased risk of fracture and reduced bone mineral density (BMD) in women taking certain antiepileptic drugs (AEDs). The second study describes the epilepsy semiology of patients with mitochondrial disorders...

  • USING ASPIRIN INTRAVENOUSLY. Diener, H.-C. // Journal of Headache & Pain;Apr2006 Supplement, Vol. 7, pS69 

    The article discusses research on the efficacy and safety of intravenous lysine acetyl salicylate (iLAS) in the acute treatment of migraine. It references a study by H. C. Diener published in a previous issue of "Cephalalgia." Findings indicated that both iLAS and sumatriptan were superior to...

  • Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. Svendsen, Kristina B.; Jensen, Troels S.; Bach, Flemming W. // BMJ: British Medical Journal (International Edition);7/31/2004, Vol. 329 Issue 7460, p253 

    Objective To evaluate the effect of the oral synthetic δ9-tetrahydrocannabinol dronabinol on central neuropathic pain in patients with multiple sclerosis. Design Randomised double blind placebo controlled crossover trial. Setting Outpatient clinic, University Hospital of Aarhus, Denmark....

  • A model-based longitudinal meta-analysis of FEV1 in randomized COPD trials. Korell, J; Martin, SW; Karlsson, MO; Ribbing, J // Clinical Pharmacology & Therapeutics;Mar2016, Vol. 99 Issue 3, p315 

    A model-based, longitudinal meta-analysis of the efficacy on morning trough forced expiratory volume in 1 second (FEV1) in chronic obstructive pulmonary disease (COPD) is presented. Literature data from 142 randomized maintenance trials were included, comprising 106,422 patients who received 19...

  • Adverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review. Langendam, Miranda W.; Tiemersma, Edine W.; van der Werf, Marieke J.; Sandgren, Andreas // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    A recent systematic review concluded that there is insufficient evidence on the effectiveness to support or reject preventive therapy for treatment of contacts of patients with multidrug resistant tuberculosis (MDR-TB). Whether preventive therapy is favorable depends both on the effectiveness...

  • Research roundup: February 2014. Greener, Mark // Nurse Prescribing;Feb2014, Vol. 12 Issue 2, p62 

    No abstract available.

  • First report of hypoalbuminaemia: 5 case reports.  // Reactions Weekly;5/15/2004, Issue 1001, p14 

    Discusses research being done on the side effects of valproate semisodium on patients with sever disability and neurological impairment. Reference to a study by T. A. Rugino and colleagues, published in the November 2003 issue of the "Pediatric Neurology"; Development of hypoalbuminaemia;...

  • Recent Advances in the Development of NR2B Subtype-Selective NMDA Receptor Antagonists. Layton, Mark E.; Kelly III, Michael J.; Rodzinak, Kevin J. // Current Topics in Medicinal Chemistry;Apr2006, Vol. 6 Issue 7, p697 

    Over activation of the NMDA receptor complex has been implicated in a number of neurological conditions. The use of NMDA antagonists as therapeutic agents has been limited by serious cognitive and motor side effects. Significant efforts have been reported in the development of NR2B...

  • Neurological disorders: case report.  // Reactions Weekly;5/15/2004, Issue 1001, p9 

    Discusses research being done on the side effects of hepatitis A vaccine on a male patient. Reference to a study by D. L. George and J. G. Benonis, published in the November 2003 issue of the "American Journal of Medicine"; Occurrence of neurological disorders; Cause of the drug's side effects.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics